l(2)CA61[VS]. - Roote, J. (1997)
Subject: l(2)CA61[VS] Hi John, Kathy asked for l(2)CA61[VS] to be entered into FlyBase. It is a new gene-allele for us and was apparently provided by you in this stock: b[1] esg[35Ce-1] pr[1] cn[1] bw[1] l(2)CA61[VS]/SM5 quote from Kathy: 'which was placed in the Mid-America Stock Center by the Ashburner lab and is now in the Bloomington collection.' Is there anything you can tell us about this stock: mutagen phenotype (I know it is lethal but at what stage etc) discoverer etc thanks, Ele > Subject: Re: l(2)CA61[VS] Hi Ele, CA61 is an unmapped gene whose existence is inferred from the lack of complementation between VS2, VS8 (both esg alleles) and Df(2L)b80k, Df(2L)b88c25 (neither of which remove esg), i.e. all four stocks are mutant for CA61. Df(2L)b80k and Df(2L)b88c25 complement all other esg alleles. VS2 and VS8 are from the same screen of Pat Simpson. b80k and b88c25 are from Alexandrov (but 8 years apart). John Subject: l(2)35Cc[AM7] Kathy wrote: >I have l(2)35Cc[AM7] in a stock from Bowling Green, to them from the >Ashburner lab. Perhaps you could get a pc on this one too from JR32. How about it then John??!! We have the gene but know nothing about the mutation. Ele > Subject: Re: l(2)35Cc[AM7] The stock is rd9. The existence of 35Cc is inferred from the lethality of rd9. I guess rd9 cannot be both a deletion and a point mutation of 35Cc. Take your pick! John